摘要
目的:观察术后化疗联合康艾注射液治疗非小细胞肺癌患者的临床疗效。方法:将120例患者随机分为观察组和对照组,每组各60例。对照组采用常规西医治疗,观察组在对照组的基础上加用康艾注射液,比较两组的临床效果。结果:治疗后,观察组患者的生活质量各维度评分和T淋巴细胞亚群等指标均较对照组患者出现了明显改善,组间差异具有明显统计学意义(P<0.05),观察组患者的毒副反应发生率为53.33%,明显低于对照组患者,组间差异具有明显统计学意义(P<0.05)。结论:术后化疗联合康艾注射液治疗对非小细胞肺癌患者具有十分显著的作用,可有效提高患者的生活质量和机体免疫功能,并在一定程度上降低患者化疗的毒副反应,有利于患者的预后恢复。
Objective: To observe the clinical effects of postoperative chemotherapy combined with Kang'ai injection to treat non-small cell lung cancer. Methods: 120 patients were randomly divided into the observation group and the control group,with 60 in each group. The patients in the control group were given conventional western medicine treatment,and the patients in the observation group were added Kang'ai injection on the basis of the treatment of the control group. Then their clinical effects were compared. Results: After the treatment,the indexes such as each dimension score of life quality and T lymphocyte subsets of the patients in the observation group were more significantly improved compared with those of the control group,and the difference between them had obvious statistical significance( P < 0. 05). The incidence rate of toxic and side effect in the observation group was 53. 33%,which was significantly lower than those of the control group,and the difference between them had obvious statistical significance( P < 0. 05). Conclusion: Postoperative chemotherapy combined with Kang'ai injection had good effects on patients with non-small cell lung cancer,whose life quality and body immune function were greatly improved. To some degree,this kind of therapy could reduce patients' toxic and side effects and is good to their recovery from the disease.
出处
《河南中医》
2014年第6期1111-1113,共3页
Henan Traditional Chinese Medicine
关键词
非小细胞肺癌
化疗
康艾注射液
non-small cell lung cancer
chemotherapy
Kang'ai injection
